Neelesh Kumar Mehra
Overview
Explore the profile of Neelesh Kumar Mehra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Valamla B, Charry S, Rajana N, Urati A, Devabattula G, Sau S, et al.
ACS Appl Bio Mater
. 2024 Jan;
7(2):1028-1040.
PMID: 38275087
The wound curation dressing material should own explicit elements to aggrandize wound cessation. The cryogel of poly(vinyl alcohol) (PVA) and hyaluronic acid (HA) is deemed to promote the angiogenesis, production...
22.
Patil S, Sandeep Chary P, Maddipatla S, Madhavi Y, Singothu S, Bhandari V, et al.
J Biomol Struct Dyn
. 2024 Jan;
:1-18.
PMID: 38247232
Cyclodextrin complexes loaded with venetoclax for improved solubility and therapeutic efficacy as repurposed drug. The venetoclax-cyclodextrin inclusion complex was prepared using kneading method. Primarily in-silico molecular docking study was performed...
23.
Rajana N, Sandeep Chary P, Bhavana V, Deshmukh R, Dukka K, Sharma A, et al.
Int J Pharm
. 2024 Jan;
651:123787.
PMID: 38184023
Targeted drug delivery is an advanced approach for active targeting of tumor that can enhance the concentration of the drug at the site of action and reduce the off-target toxicity...
24.
Anuradha U, Mehra N, Khatri D
Mol Biol Rep
. 2024 Jan;
51(1):82.
PMID: 38183502
In today's culture, obesity and overweight are serious issues that have an impact on how quickly diabetes develops and how it causes complications. For the development of more effective therapies,...
25.
Rajana N, Pooja Y, Bhavana V, Sandeep Chary P, Dukka K, Deshmukh R, et al.
Biomed Chromatogr
. 2023 Dec;
38(4):e5815.
PMID: 38128133
The current research involved the development and validation of an easy, cost-effective, and sensitive bioanalytical reverse-phase high-performance liquid chromatography method for the assessment of palbociclib (PAL) in rat plasma and...
26.
Pooja Y, Rajana N, Yadav R, Naraharisetti L, Godugu C, Mehra N
Int J Biol Macromol
. 2023 Dec;
258(Pt 1):128821.
PMID: 38110163
Our main aim to design and develop a novel 4-carboxy phenyl boronic acid (4-CPBA) conjugated Palbociclib (PALB) loaded pH-sensitive chitosan lipid nanoparticles (PPCL) to enhance the anti-cancer efficacy of the...
27.
Dinakar Y, Rajana N, Kumari N, Jain V, Mehra N
AAPS PharmSciTech
. 2023 Dec;
24(8):258.
PMID: 38097825
Even though chemotherapy stands as a standard option in the therapy of TNBC, problems associated with it such as anemia, bone marrow suppression, immune suppression, toxic effects on healthy cells,...
28.
Yadav R, Bhawale R, Kapoor D, Singh S, Mehra N
Pharm Dev Technol
. 2023 Nov;
29(1):1-12.
PMID: 38015058
One of the most prevalent cancers affecting women globally is cervical cancer. Cervical cancer is thought to cause 570 000 new cases annually, and standard treatments can have serious side...
29.
Rajana N, Sandeep Chary P, Pooja Y, Bhavana V, Singh H, Guru S, et al.
Drug Deliv Transl Res
. 2023 Nov;
14(5):1277-1300.
PMID: 37953430
Breast cancer is reported as one of the most prevalent non-cutaneous malignancies in women. Venetoclax (VEN) is an approved BCl-2 inhibitor for the treatment of chronic myeloid leukemia with very...
30.
Panwar D, Thakor P, Sharma M, Bakshi A, Bhavana V, Srivastava V, et al.
Nanomedicine (Lond)
. 2023 Aug;
18(15):1005-1023.
PMID: 37530043
This investigation aims to repurpose venetoclax using hyaluronic acid-coated venetoclax nanocrystals (HA-VEN-NCs) to target breast cancer. An antisolvent precipitation method was used to fabricate the nanocrystals and optimize them using...